ArticleArchives of dermatological research2022

Chemokine level predicts the therapeutic effect of anti-PD-1 antibody (nivolumab) therapy for malignant melanoma.

Kenta Nakamura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.